Logo image of BWAY

BRAINSWAY LTD-ADR (BWAY) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BWAY - US10501L1061 - ADR

17.27 USD
+0.14 (+0.82%)
Last: 12/5/2025, 8:06:12 PM
17.27 USD
0 (0%)
After Hours: 12/5/2025, 8:06:12 PM
Fundamental Rating

6

Taking everything into account, BWAY scores 6 out of 10 in our fundamental rating. BWAY was compared to 188 industry peers in the Health Care Equipment & Supplies industry. While BWAY has a great health rating, its profitability is only average at the moment. BWAY has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination! This makes BWAY very considerable for value and growth investing!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year BWAY was profitable.
In the past year BWAY had a positive cash flow from operations.
In the past 5 years BWAY reported 4 times negative net income.
In multiple years BWAY reported negative operating cash flow during the last 5 years.
BWAY Yearly Net Income VS EBIT VS OCF VS FCFBWAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

With an excellent Return On Assets value of 4.79%, BWAY belongs to the best of the industry, outperforming 80.85% of the companies in the same industry.
Looking at the Return On Equity, with a value of 7.84%, BWAY belongs to the top of the industry, outperforming 81.91% of the companies in the same industry.
The Return On Invested Capital of BWAY (1.83%) is better than 69.15% of its industry peers.
Industry RankSector Rank
ROA 4.79%
ROE 7.84%
ROIC 1.83%
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
BWAY Yearly ROA, ROE, ROICBWAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

BWAY has a better Profit Margin (11.60%) than 86.17% of its industry peers.
BWAY has a Operating Margin of 4.05%. This is in the better half of the industry: BWAY outperforms 68.62% of its industry peers.
BWAY has a Gross Margin of 74.52%. This is amongst the best in the industry. BWAY outperforms 85.11% of its industry peers.
BWAY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.05%
PM (TTM) 11.6%
GM 74.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
BWAY Yearly Profit, Operating, Gross MarginsBWAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BWAY is destroying value.
The number of shares outstanding for BWAY has been increased compared to 1 year ago.
The number of shares outstanding for BWAY has been increased compared to 5 years ago.
BWAY has a worse debt/assets ratio than last year.
BWAY Yearly Shares OutstandingBWAY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
BWAY Yearly Total Debt VS Total AssetsBWAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 4.67 indicates that BWAY is not in any danger for bankruptcy at the moment.
BWAY has a Altman-Z score of 4.67. This is in the better half of the industry: BWAY outperforms 76.60% of its industry peers.
BWAY has a debt to FCF ratio of 0.33. This is a very positive value and a sign of high solvency as it would only need 0.33 years to pay back of all of its debts.
BWAY's Debt to FCF ratio of 0.33 is amongst the best of the industry. BWAY outperforms 92.55% of its industry peers.
BWAY has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.08, BWAY is in the better half of the industry, outperforming 66.49% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.33
Altman-Z 4.67
ROIC/WACC0.21
WACC8.56%
BWAY Yearly LT Debt VS Equity VS FCFBWAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

BWAY has a Current Ratio of 3.51. This indicates that BWAY is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of BWAY (3.51) is better than 63.83% of its industry peers.
BWAY has a Quick Ratio of 3.34. This indicates that BWAY is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 3.34, BWAY is doing good in the industry, outperforming 71.28% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.51
Quick Ratio 3.34
BWAY Yearly Current Assets VS Current LiabilitesBWAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 260.14% over the past year.
The Revenue has grown by 29.04% in the past year. This is a very strong growth!
The Revenue has been growing by 12.17% on average over the past years. This is quite good.
EPS 1Y (TTM)260.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.08%
Revenue 1Y (TTM)29.04%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%16.38%

3.2 Future

The Earnings Per Share is expected to grow by 53.27% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 19.29% on average over the next years. This is quite good.
EPS Next Y58.83%
EPS Next 2Y54.54%
EPS Next 3Y53.27%
EPS Next 5YN/A
Revenue Next Year15%
Revenue Next 2Y18.5%
Revenue Next 3Y19.29%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BWAY Yearly Revenue VS EstimatesBWAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
BWAY Yearly EPS VS EstimatesBWAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 -2

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.70 indicates a correct valuation of BWAY.
Based on the Price/Earnings ratio, BWAY is valued cheaper than 86.70% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.46, BWAY is valued a bit cheaper.
With a Price/Forward Earnings ratio of 11.79, the valuation of BWAY can be described as very reasonable.
91.49% of the companies in the same industry are more expensive than BWAY, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.10, BWAY is valued rather cheaply.
Industry RankSector Rank
PE 15.7
Fwd PE 11.79
BWAY Price Earnings VS Forward Price EarningsBWAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BWAY is valued a bit cheaper than the industry average as 65.43% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, BWAY is valued cheaper than 92.02% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.04
EV/EBITDA 66.63
BWAY Per share dataBWAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BWAY's earnings are expected to grow with 53.27% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.27
PEG (5Y)N/A
EPS Next 2Y54.54%
EPS Next 3Y53.27%

0

5. Dividend

5.1 Amount

No dividends for BWAY!.
Industry RankSector Rank
Dividend Yield N/A

BRAINSWAY LTD-ADR

NASDAQ:BWAY (12/5/2025, 8:06:12 PM)

After market: 17.27 0 (0%)

17.27

+0.14 (+0.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-11 2025-11-11/dmh
Earnings (Next)03-09 2026-03-09/bmo
Inst Owners4.88%
Inst Owner Change-5.42%
Ins Owners16.12%
Ins Owner ChangeN/A
Market Cap337.81M
Revenue(TTM)41.02M
Net Income(TTM)5.34M
Analysts85.71
Price Target0.12 (-99.31%)
Short Float %0.31%
Short Ratio0.76
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)36.24%
Min EPS beat(2)-22.64%
Max EPS beat(2)95.12%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.21%
Min Revenue beat(2)-2.35%
Max Revenue beat(2)-0.08%
Revenue beat(4)2
Avg Revenue beat(4)-0.57%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)0.15%
Revenue beat(8)5
Avg Revenue beat(8)0.76%
Revenue beat(12)6
Avg Revenue beat(12)-18.08%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.61%
PT rev (3m)20.36%
EPS NQ rev (1m)-2.85%
EPS NQ rev (3m)-29.22%
EPS NY rev (1m)-2.85%
EPS NY rev (3m)-29.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.88%
Valuation
Industry RankSector Rank
PE 15.7
Fwd PE 11.79
P/S 7.33
P/FCF 18.04
P/OCF 14.59
P/B 4.96
P/tB 4.96
EV/EBITDA 66.63
EPS(TTM)1.1
EY6.37%
EPS(NY)1.47
Fwd EY8.48%
FCF(TTM)0.96
FCFY5.54%
OCF(TTM)1.18
OCFY6.86%
SpS2.36
BVpS3.48
TBVpS3.48
PEG (NY)0.27
PEG (5Y)N/A
Graham Number9.28
Profitability
Industry RankSector Rank
ROA 4.79%
ROE 7.84%
ROCE 2.17%
ROIC 1.83%
ROICexc 19.56%
ROICexgc 19.56%
OM 4.05%
PM (TTM) 11.6%
GM 74.52%
FCFM 40.64%
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
F-Score4
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.33
Debt/EBITDA 1.37
Cap/Depr 229.33%
Cap/Sales 9.62%
Interest Coverage 11.81
Cash Conversion 609.66%
Profit Quality 350.45%
Current Ratio 3.51
Quick Ratio 3.34
Altman-Z 4.67
F-Score4
WACC8.56%
ROIC/WACC0.21
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)260.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.08%
EPS Next Y58.83%
EPS Next 2Y54.54%
EPS Next 3Y53.27%
EPS Next 5YN/A
Revenue 1Y (TTM)29.04%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%16.38%
Revenue Next Year15%
Revenue Next 2Y18.5%
Revenue Next 3Y19.29%
Revenue Next 5YN/A
EBIT growth 1Y155.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-6.13%
EBIT Next 3Y41.44%
EBIT Next 5YN/A
FCF growth 1Y321.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y429.93%
OCF growth 3Y127.03%
OCF growth 5YN/A

BRAINSWAY LTD-ADR / BWAY FAQ

What is the fundamental rating for BWAY stock?

ChartMill assigns a fundamental rating of 6 / 10 to BWAY.


What is the valuation status for BWAY stock?

ChartMill assigns a valuation rating of 8 / 10 to BRAINSWAY LTD-ADR (BWAY). This can be considered as Undervalued.


How profitable is BRAINSWAY LTD-ADR (BWAY) stock?

BRAINSWAY LTD-ADR (BWAY) has a profitability rating of 5 / 10.


What is the valuation of BRAINSWAY LTD-ADR based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BRAINSWAY LTD-ADR (BWAY) is 15.7 and the Price/Book (PB) ratio is 4.96.